Hee Ho Chu

Hee Ho Chu

Auto-generated profile, based on publicly available information

Hee Ho Chu

Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
YCYuri Cho
Yuri Cho
JCJin Woo Choi
Jin Woo Choi
HKHoon Kwon
Hoon Kwon
KKKun Yung Kim
Kun Yung Kim
BLByung Chan Lee
Byung Chan Lee
RAResearch Committee of the Korean Liver Cancer Association
Research Committee of the Korean Liver Cancer Association
Cho Y, et al. Korean J Radiol. 2023 Jun;24:e35. https://doi.org/10.3348/kjr.2023.0385

30 September 2023 in Journal of Liver Cancer
Verified
Journal Article
Open access
PDF file
YCYuri Cho
Yuri Cho
JCJin Woo Choi
Jin Woo Choi
HKHoon Kwon
Hoon Kwon
KKKun Yung Kim
Kun Yung Kim
BLByung Chan Lee
Byung Chan Lee
RAResearch Committee of the Korean Liver Cancer Association
Research Committee of the Korean Liver Cancer Association
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established as conventional TACE using Lipiodol in the 1980s. In the 2000s, drug-eluting beads were developed and applied clinically. Currently, TACE is a commonly used non-surgical treatment modality for patients with HCC who are unsuitable for curative treatment. Considering the vital role of TACE in the management of HCC, it is crucial to organize current knowledge and expert opinions regarding patient preparation, procedural techniques, and post-treatment care in TACE, which can enhance therapeutic efficacy and safety. A group of 12 experts in the fields of interventional radiology and hepatology, convened by the Research Committee of the Korean Liver Cancer Association (KLCA), has developed expert consensus-based practical recommendations in TACE. These recommendations have been endorsed by the Korean Society of Interventional Radiology and provide useful information and direction in performing TACE procedure as well as pre- and post- procedural patient care.

29 April 2020 in Cancers
Verified
Journal Article
Open access
PDF file
HCHee Ho Chu
Hee Ho Chu
Jin Hyoung KimJin Hyoung Kim
Jin Hyoung Kim
JSJu Hyun Shim
Ju Hyun Shim
SYSang Min Yoon
Sang Min Yoon
PKPyeong Hwa Kim
Pyeong Hwa Kim
IAIBRAHIM ALRASHIDI
IBRAHIM ALRASHIDI
A combination of transarterial chemoembolization (TACE) plus sorafenib or radiotherapy (RT) has demonstrated efficacy in patients with advanced hepatocellular carcinoma (HCC). Here, the two combined treatment approaches were compared in patients with HCC and portal vein tumor thrombus (PVTT). Data from 307 patients treated with TACE plus RT (n = 203) or TACE plus sorafenib (n = 104) as first-line treatment for HCC with PVTT were retrospectively evaluated. Using the propensity model to correct selection bias, 87 patients were included from each treatment group. During follow up (median, 12 months) in the entire study population, the median progression-free survival (PFS) and overall survival (OS) were significantly longer in the TACE plus RT group than in the TACE plus sorafenib group (6.5 vs. 4.3 months, respectively; p = 0.017 and 16.4 vs. 12 months, respectively; p = 0.007). Following propensity score matching, the median PFS and OS in the two groups showed no statistically significant difference. Multivariable analysis found no significant association between PFS or OS and the treatment type. In conclusion, this retrospective study of data from patients with advanced HCC with PVTT shows that PFS and OS did not differ significantly in patients treated with TACE plus RT and TACE plus sorafenib.

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
CPChan Park
Chan Park
Jin Hyoung KimJin Hyoung Kim
Jin Hyoung Kim
PKPyeong Hwa Kim
Pyeong Hwa Kim
SKSo Yeon Kim
So Yeon Kim
DGDONG IL GWON
DONG IL GWON
DKDong Joon Kim
Dong Joon Kim
Park C, et al. Korean J Radiol. 2020 Jul;21:e148. https://doi.org/10.3348/kjr.2020.0325

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
GKGun Ha Kim
Gun Ha Kim
Jin Hyoung KimJin Hyoung Kim
Jin Hyoung Kim
PKPyeong Hwa Kim
Pyeong Hwa Kim
HCHee Ho Chu
Hee Ho Chu
DGDONG IL GWON
DONG IL GWON
HKHeung-Kyu Ko
Heung-Kyu Ko
Kim GH, et al. Korean J Radiol. 2021 Aug;22:e110. https://doi.org/10.3348/kjr.2021.0229

1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JKJi Hye Kwon
Ji Hye Kwon
DGDONG IL GWON
DONG IL GWON
JKJong Woo Kim
Jong Woo Kim
HCHee Ho Chu
Hee Ho Chu
Jin Hyoung KimJin Hyoung Kim
Jin Hyoung Kim
KSKyu-Bo Sung
Kyu-Bo Sung
Kwon JH, et al. Korean J Radiol. 2020 Feb;21:e67. https://doi.org/10.3348/kjr.2019.0753